Filter
1971
Filtered Results: 1971
Text search:
drug
regimens
Featured
Recommendations
205
New Publications
533
Language
Document type
No document type
1293
Guidelines
274
Studies & Reports
233
Manuals
58
Strategic & Response Plan
34
Fact sheets
34
Training Material
23
Situation Updates
7
Infographics
7
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
121
South Africa
63
Kenya
52
Ethiopia
49
Global
47
Tanzania
45
Western and Central Europe
42
Uganda
37
Nigeria
35
Zambia
34
Nepal
31
Eastern Europe
31
Rwanda
28
Africa
28
Malawi
24
Ghana
22
Liberia
21
Ukraine
21
Latin America and the Carribbean
21
Philippines
18
Bangladesh
18
Namibia
18
Myanmar / Burma
18
Asia
17
Zimbabwe
16
Cambodia
15
Sierra Leone
12
Mozambique
12
Russia
12
Indonesia
11
Lesotho
11
South–East Asia Region
11
Botswana
10
Eswatini/ Swaziland
8
Senegal
7
Cameroon
7
Thailand
7
Colombia
7
Congo, Democratic Republic of
6
Brazil
6
Haiti
5
East and Southern Africa
5
West and Central Africa
5
Albania
5
Georgia
5
USA
4
Pakistan
4
Syria
4
Argentina
4
Venezuela
4
Tajikistan
4
South Sudan
3
Germany
3
China
3
Benin
3
Western Pacific Region
3
Bhutan
3
Estonia
3
Vietnam
3
Jamaica
3
Burkina Faso
2
Somalia
2
Iraq
2
Afghanistan
2
Sudan
2
Sri Lanka
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Timor Leste/ East Timor
2
Romania
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Jordan
1
Lebanon
1
Gambia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
North Macedonia
1
El Salvador
1
Bolivia
1
Greece
1
Chile
1
Fiji
1
Solomon Islands
1
North Korea
1
Laos
1
Iran
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
716
Clinical Guidelines
283
Public Health
83
Women & Child Health
69
Capacity Building
42
Pharmacy & Technologies
18
Key Resources
16
Toolboxes
TB
374
HIV
352
AMR
77
NTDs
72
Pharmacy
60
Mental Health
46
COVID-19
45
NCDs
45
Ebola
29
Refugee
23
Caregiver
21
Conflict
16
Rapid Response
15
Polio
11
Disability
9
Health Financing Toolbox
5
Natural Hazards
4
Specific Hazards
4
Planetary Health
4
Cholera
3
Global Health Education
3
Social Ethics
3
Zika
1
WHO recommendations on newborn health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be delivered during pregnancy, childbirth and the postnatal period?
■ What health behaviours should the women practise (or not practise) during these periods to care for ...
This document is meant to respond to the questions:
■ What health interventions should be delivered during pregnancy, childbirth and the postnatal period?
■ What health behaviours should the women practise (or not practise) during these periods to care for ...
This document was prepared in response to a need to review and potentially update the current recommendations for the antibiotic treatment of both inpatient and outpatient management of severe acute malnutrition (SAM). The current recommendations (Table 1) are based on guidelines published in 2013 i...
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended...
This 2016-2020 public-private mix strategic plan (PPM SP) is a 4-year framework designed to guide the National TB Control Programme (NTP) and its partners to implement PPM in Bangladesh. It provides goals, strategies and interventions for expanding and scaling up current PPM models and outlines appr...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also ...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
